Zhongwu Lai

5PUBLICATIONS
110CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 27, 2026
The genomic landscape and treatment outcomes associated with CDKN2A/MTAP loss in patients with non-small cell lung cancer.

|Mar 13, 2025
Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor Outcomes.

Patricia McCoon, Ying Wang, Zhongwu Lai

|Oct 06, 2023
Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden.

Luis Paz-Ares, Marina Chiara Garassino, Yuanbin Chen

|Aug 31, 2022
Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound.

Kim N Chi, Alan Barnicle, Caroline Sibilla

|Aug 03, 2022
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance.

Violeta Serra, Anderson T Wang, Marta Castroviejo-Bermejo

Pageof 1

Frequent Collaborators

2 joint publications

J Carl Barrett

1 joint publications

Violeta Serra

1 joint publications

Anderson T Wang

1 joint publications

Marta Castroviejo-Bermejo